Question 1

Am I eligible for this trial based on my kidney function and current health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function clinical trial (NCT01393964). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function clinical trial (NCT01393964). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of Elotuzumab, Lenalidomide, and Dexamethasone?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function clinical trial (NCT01393964). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function clinical trial (NCT01393964). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment cycles?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function clinical trial (NCT01393964). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific risks I should be aware of given my kidney condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function clinical trial (NCT01393964). Contact the study team or your healthcare provider for specific answers.

What this study is about